Molecular interactions in the activation of effector and precursor cytotoxic T lymphocytes
- PMID: 7493753
- DOI: 10.1111/j.1600-065x.1995.tb00689.x
Molecular interactions in the activation of effector and precursor cytotoxic T lymphocytes
Abstract
Cell-cell interactions are influenced by parameters that cannot readily be studied using either intact cells or soluble molecules. Replacing one of the pair of interacting cells with an artificial cell surface construct allows novel insights to be gained into some of these parameters. Application of this approach to the study of CTL has helped to clarify the contrasting roles of some of the various receptors that are involved in recognition, adhesion and activation. In addition, it has revealed features of these receptor ligand interactions that help to explain how CTL are able to carry out effective immune surveillance and elimination of virus-infected or tumor cells. Although not discussed in this review, artificial cell surface constructs have also been effectively employed to study the interaction of TH cells with class II bearing surfaces. Class I protein and peptide antigen can be sufficient to mediate adhesion and activate CTL effector function through the TCR and CD8. In addition, interactions of other co-receptors with their ligands can act along with TCR and CD8 in a cascade of activated adhesion and co-stimulatory signal generation to allow adhesion and response when antigen and/or class I surface densities are too low to be sufficient by themselves to initiate response. The relative contributions of the various receptor/ligand interactions to a given CTL/target encounter will depend upon the affinity of the TCR for antigen and on the densities and types of ligands, including antigen, displayed on the target cell surface. It appears that the CTL has the ability to accomplish its task in a variety of ways, providing it with considerable flexibility in recognizing and eliminating antigen-bearing target cells. Thus, downregulation of any one particular ligand on a virus-infected or tumor cell does not allow escape from CTL surveillance provided that at least a low level of class I antigen remains present. The CTL is able to employ several co-receptors specific for ligands common to many cell types without being diverted from effective immune surveillance, since these receptors only become activated to mediate high-avidity adhesion when antigen is detected by the TCR. Cloned effector CTL are most amenable to studies of the kind reviewed here, since large numbers of homogenous cells can be obtained, antigen-specific adhesion can be readily measured and response is rapid and easily quantitated.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Characterization of anti-CD8-resistant cytolytic T lymphocytes induced by multivalent cross-linking of CD8 on precursor cells.J Immunol. 1989 Oct 1;143(7):2112-9. J Immunol. 1989. PMID: 2528588
-
Interplay between the TCR/CD3 complex and CD4 or CD8 in the activation of cytotoxic T lymphocytes.Immunol Rev. 1989 Jun;109:119-41. doi: 10.1111/j.1600-065x.1989.tb00022.x. Immunol Rev. 1989. PMID: 2527803 Review.
-
Glu227-->Lys substitution in the acidic loop of major histocompatibility complex class I alpha 3 domain distinguishes low avidity CD8 coreceptor and avidity-enhanced CD8 accessory functions.J Exp Med. 1996 Nov 1;184(5):1671-83. doi: 10.1084/jem.184.5.1671. J Exp Med. 1996. PMID: 8920857 Free PMC article.
-
Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.Immunol Cell Biol. 1993 Aug;71 ( Pt 4):311-26. doi: 10.1038/icb.1993.36. Immunol Cell Biol. 1993. PMID: 7901150
-
Molecular mechanisms and biological significance of CTL avidity.Curr HIV Res. 2003 Jul;1(3):287-94. doi: 10.2174/1570162033485230. Curr HIV Res. 2003. PMID: 15046253 Review.
Cited by
-
Adoptive immunotherapy combined with FP treatment for head and neck cancer: An in vitro study.Int J Oncol. 2017 Nov;51(5):1471-1481. doi: 10.3892/ijo.2017.4142. Epub 2017 Oct 2. Int J Oncol. 2017. PMID: 29048671 Free PMC article.
-
Anti-interleukin-2 receptor antibodies for the prevention of rejection in pediatric renal transplant patients: current status.Paediatr Drugs. 2003;5(10):699-716. doi: 10.2165/00148581-200305100-00005. Paediatr Drugs. 2003. PMID: 14510627 Review.
-
Immunomodulatory effect of zidovudine (ZDV) on cytotoxic T lymphocytes previously exposed to ZDV.Antimicrob Agents Chemother. 2002 Sep;46(9):2865-71. doi: 10.1128/AAC.46.9.2865-2871.2002. Antimicrob Agents Chemother. 2002. PMID: 12183239 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials